- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fischer suffers another poor quarter
X-ray vendor Fischer Imaging continues to be plagued by a 50% drop in sales to OEMs. Hurt primarily by an ongoing decline in shipments of the Tilt-C tilting C-arm to GE Medical Systems, the Denver-based company reported a 31% drop in revenues in its
X-ray vendor Fischer Imaging continues to be plagued by a 50% drop in sales to OEMs. Hurt primarily by an ongoing decline in shipments of the Tilt-C tilting C-arm to GE Medical Systems, the Denver-based company reported a 31% drop in revenues in its second quarter (end-June).
Fischer posted revenues of $15.2 million, compared with $21.9 million in 1996. The company had a net loss of $1.4 million, compared with earnings of $946,000 in the same period in 1996.
While revenues were up 23% compared with the vendor's first-quarter results (SCAN 4/30/97), Fischer still remains sharply off last year's six-month pace. For the first six months of 1997, the company had revenues of $27.5 million, compared with $42 million in the same period in 1996. Fischer reported a net loss of $5.3 million in the first half, compared with net income of $2 million in 1996.
The news from Fischer wasn't all bad, however. Mammography system sales were up 42% in the second quarter, and the company has reduced its inventory in the first half of the year by $5.2 million. Fischer has $5.1 million in cash and remains essentially debt-free, according to Morgan Nields, chairman and CEO.
The company's primary R&D objective remains the completion of a clinical trial for its SenoScan full-field digital mammography system, which is now operating at five centers in the U.S. and Canada. Some of these sites are gathering data to support the company's 510(k) submission to the Food and Drug Administration, according to the company.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
